Advertisement

Topics

RXi Pharmaceuticals Corp RXII Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

14:43 EST 15 Nov 2017 | BioPortfolio Reports

Summary


RXi Pharmaceuticals Corp RXi is a biotechnology company that discovers, develops and commercializes therapies based on RNAi platform. The company's products comprise RXI109 and samcyprone gel. Its RXI109 is an RNAi compound, which is used to reduce the expression of critical regulator of several biological pathways in fibrosis such as scar formation in the skin. RXi offers products for the treatment of anti scarring, macular degeneration, retinoblastoma, and liver diseases. The company uses RNAi and sdrxRNA technologies for the development of products. It partners with academia, biotech, and large multinational organizations for the development of new therapeutics. RXi is headquartered in Marlborough, Massachusetts, the US.


RXi Pharmaceuticals Corp Key Recent Developments


Nov 08,2017: RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

Nov 07,2017: RXi Pharmaceuticals Announces Participation in Leading European Healthcare Forums and Conferences

Oct 11,2017: RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum

Sep 18,2017: RXi Pharmaceuticals to Present at BioPharm America's 10th Annual International Partnering Conference

Sep 15,2017: RXi Pharmaceuticals Announces the Departure of Dr. Alexey Eliseev as Chief Business Officer


This comprehensive SWOT profile of RXi Pharmaceuticals Corp provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RXi Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.


The profile contains critical company information including*,


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Note*: Some sections may be missing if data is unavailable for the company.


Key benefits of buying this profile include,


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: RXi Pharmaceuticals Corp RXII Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "RXi Pharmaceuticals Corp RXII Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...